Cytheris
Latest round
- Series D
Last raised
- Jun 2010
Total raised
- $56M
Investors
- 7
About Cytheris
Founded in 1999, Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).
Who invested in Cytheris
7 investors across 3 rounds
See all investors in Cytheris
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cytheris
Who invested in Cytheris?
Cytheris has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytheris raised?
Cytheris has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cytheris last raise money?
Cytheris's most recent round on record is a Series D, in Jun 2010.
What does Cytheris do?
Founded in 1999, Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.
Where is Cytheris headquartered?
Cytheris is headquartered in Issy-les-Moulineaux, France.
Which VCs invest in companies like Cytheris?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Cytheris's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Cytheris? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.